Prokidney (PROK) Depreciation & Amortization (CF) (2021 - 2026)
Prokidney's (PROK) quarterly Depreciation & Amortization (CF) came in at $1.7 million in Q1 2026, up 3.62% year-on-year from $1.6 million in Q1 2025, and down 9.74% on a QoQ basis from $1.8 million in Q4 2025.
Prokidney (PROK) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $1.7 million in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 3.62% year-over-year to $1.7 million in Q1 2026; TTM through Mar 2026 was $6.4 million, a 19.62% increase from a year earlier, with the FY2025 full-year figure at $6.6 million, up 21.04% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $1.7 million, down from $1.8 million in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for PROK reached as high as $1.8 million in Q4 2025 and fell as low as $710000.0 in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $1.2 million across 5 years, with a median of $1.1 million in 2024.
- Across the five-year window, Depreciation & Amortization (CF) jumped 95.26% in 2022 and advanced 3.62% in 2026, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $791000.0 in 2022, then jumped by 44.88% to $1.1 million in 2023, then surged by 37.35% to $1.6 million in 2024, then climbed by 16.71% to $1.8 million in 2025, then declined by 9.74% to $1.7 million in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $1.7 million in Q1 2026, $1.8 million in Q4 2025, and $1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 41.14 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 2.20 Mn |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - | 1.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.66 Mn |
| Mar 31, 2026 | 1.66 Mn |
| Dec 31, 2025 | 1.84 Mn |
| Dec 31, 2025 | 1.84 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | 1.49 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 964,000.00 |
| Jun 30, 2024 | 964,000.00 |
| Mar 31, 2024 | 1.10 Mn |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 1.15 Mn |
| Dec 31, 2023 | 1.15 Mn |